Marshall Wace’s Raptor Pharmaceutical RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
– Sell
-386,825
Closed -$1.78M – 1330
2016
Q1
$1.78M Buy
+386,825
New +$1.55M 0.02% 584
2015
Q3
– Sell
-381,765
Closed -$6.03M – 1242
2015
Q2
$6.03M Buy
+381,765
New +$4.64M 0.08% 270

Other funds holding RPTP

Marshall Wace's RPTP Position: Q2 2016 in Review

Marshall Wace sold out of Raptor Pharmaceutical (RPTP) in Q2 2016, closing a stake of 386,825 shares — an estimated $1.78M sold.

Marshall Wace first reported a position in RPTP in Q2 2015 and held it in 2 quarters. The position peaked at $6.03M in Q2 2015. 93 funds tracked by Wall St. Rank hold RPTP as of Q2 2016.

  • Marshall Wace reported no remaining Raptor Pharmaceutical position as of Q2 2016 after selling out during the quarter.
  • Marshall Wace sold 386,825 Raptor Pharmaceutical shares in Q2 2016, an estimated $1.78M.
  • Marshall Wace first reported a position in Raptor Pharmaceutical in Q2 2015 and held it in 2 quarters.
  • Marshall Wace's Raptor Pharmaceutical position peaked at $6.03M in Q2 2015.
  • 93 funds tracked by Wall St. Rank held Raptor Pharmaceutical as of Q2 2016.

Based on Marshall Wace's 13F filing for Q2 2016, filed 12 Aug 2016.